Difficulties in diagnosis and treatment of Paget's disease

被引:0
|
作者
Kawalec, Aleksandra [1 ]
Zdrojowy-Welna, Aleksandra [2 ]
Bednarek-Tupikowska, Grazyna [2 ]
机构
[1] Salmed Specialized Clin Swiebodzice, Swiebodzice, Poland
[2] Med Univ Wroclaw, Clin Endocrinol Diabetol & Isotope Therapy, Independent Publ Teaching Hosp Wroclaw 1, Wroclaw, Poland
来源
关键词
Paget's disease; alkaline phosphatase; bisphosphonates;
D O I
10.5114/fmpcr.2016.63712
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Paget's disease is a rare finding in Poland. It is a disorder of the osteoarticular system, which, in adults, mostly affects people over 55 years of age. The clinical picture varies, depending on the location of the lesions, making the diagnosis difficult, sometimes taking many years for a correct diagnosis to be made. In etiopathogenesis, genetic predispositions as well as viral infections play an important role. From the genetic point of view, Paget's disease is heterogeneous, as numerous mutations are known, and the genotype to phenotype relationship is unclear. The first phase of the disease is characterized by an increased osteolytic activity, due to morphologically changed and RANKL overstimulated osteocytes. This leads to an intensification of ossification processes that occur in a chaotic manner. Therefore, the resulting bone is weak, extensively vascularized and there is an increased risk of fracture or deformity. Clinical manifestations of Paget's disease might include pain, excessive warmth, bone deformations, degenerative lesions in the adjacent joints, compression of the neural structures, hearing loss, and dilated cardiomiopathy. Other possible complications include the development of benign and malignant bone tumors and hypercalcaemia in the case of immobilization. An elevated level of serum alkaline phosphatase, bone x-ray and bone scintigraphy are crucial in making the diagnosis. The disease should be distinguished from osteomalacia, osteoporosis, hyperparathyroidism and multiple myeloma. Bisphosphonates at doses higher than those applied for osteoporosis are an effective treatment. The occurrence of orthopedic, neurological and laryngological complications is often a reason for surgical intervention.
引用
收藏
页码:501 / 505
页数:5
相关论文
共 50 条
  • [21] Zoledronate in the treatment of Paget's disease
    Siris, E
    BRITISH JOURNAL OF CLINICAL PRACTICE, 1996, : 19 - 20
  • [22] Treatment of Paget's disease of bone
    Lojo Oliveira, Leticia
    Torrijos Eslava, Antonio
    REUMATOLOGIA CLINICA, 2012, 8 (04): : 220 - 224
  • [23] Treatment of Paget's Disease of Bone
    Urteaga, Elizabeth M.
    US PHARMACIST, 2012, 37 (10) : 29 - 34
  • [24] Treatment of extramammary Paget's disease
    ElSharkawi, AMM
    BRITISH JOURNAL OF DERMATOLOGY, 1996, 134 (06) : 1154 - 1154
  • [25] ZOLEDRONATE IN THE TREATMENT OF PAGET'S DISEASE
    Bhatia, A.
    Chung, G.
    Allsworth, A.
    Keen, R.
    RHEUMATOLOGY, 2003, 42 : 25 - 25
  • [26] The endocrine treatment of paget's disease
    Berman, L
    ENDOCRINOLOGY, 1932, 16 (02) : 109 - 119
  • [27] Treatment of Paget's disease with hypercalcemia
    Gutteridge, Donald H.
    BONE, 2006, 39 (03) : 668 - 668
  • [28] Treatment of Paget's disease with tiludronate
    Fraser, WD
    BONE, 1999, 24 (05) : 68S - 68S
  • [29] Treatment of Paget's disease - medication
    Kasperk, Ch
    OSTEOLOGIE, 2011, 20 (02) : 135 - 137
  • [30] Treatment of Paget's disease of bone
    Arias M, Garcia
    Eslava A, Torrijos
    REVISTA DE OSTEOPOROSIS Y METABOLISMO MINERAL, 2011, 3 (01) : 35 - 40